ESR1 and neoplasm: We therefore propose that high expression of GD3S in ER-negative tumors, due to the loss of ERα signaling, could increase complex gangliosides expression at the cell surface, and through this possibly enhance the aggressiveness of this tumor subtype [21], [23].